Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Authors:
Chrysalyne D. Schmults Dana-Farber/Brigham and Women’s Cancer Center | Mass General Cancer Center

Search for other papers by Chrysalyne D. Schmults in
Current site
Google Scholar
PubMed
Close
 MD, MS
,
Rachel Blitzblau Duke Cancer Institute

Search for other papers by Rachel Blitzblau in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Sumaira Z. Aasi Stanford Cancer Institute

Search for other papers by Sumaira Z. Aasi in
Current site
Google Scholar
PubMed
Close
 MD
,
Murad Alam Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Search for other papers by Murad Alam in
Current site
Google Scholar
PubMed
Close
 MD, MBA, MSCI
,
Arya Amini City of Hope National Medical Center

Search for other papers by Arya Amini in
Current site
Google Scholar
PubMed
Close
 MD
,
Kristin Bibee The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Search for other papers by Kristin Bibee in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Jeremy Bordeaux Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

Search for other papers by Jeremy Bordeaux in
Current site
Google Scholar
PubMed
Close
 MD, MPH
,
Pei-Ling Chen Moffitt Cancer Center

Search for other papers by Pei-Ling Chen in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Carlo M. Contreras The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Search for other papers by Carlo M. Contreras in
Current site
Google Scholar
PubMed
Close
 MD
,
Dominick DiMaio Fred & Pamela Buffett Cancer Center

Search for other papers by Dominick DiMaio in
Current site
Google Scholar
PubMed
Close
 MD
,
Jessica M. Donigan Huntsman Cancer Institute at the University of Utah

Search for other papers by Jessica M. Donigan in
Current site
Google Scholar
PubMed
Close
 MD
,
Jeffrey M. Farma Fox Chase Cancer Center

Search for other papers by Jeffrey M. Farma in
Current site
Google Scholar
PubMed
Close
 MD
,
Karthik Ghosh Mayo Clinic Comprehensive Cancer Center

Search for other papers by Karthik Ghosh in
Current site
Google Scholar
PubMed
Close
 MD
,
Kelly Harms University of Michigan Rogel Cancer Center

Search for other papers by Kelly Harms in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Alan L. Ho Memorial Sloan Kettering Cancer Center

Search for other papers by Alan L. Ho in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
John Nicholas Lukens Abramson Cancer Center at the University of Pennsylvania

Search for other papers by John Nicholas Lukens in
Current site
Google Scholar
PubMed
Close
 MD
,
Lawrence Mark Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Search for other papers by Lawrence Mark in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Theresa Medina University of Colorado Cancer Center

Search for other papers by Theresa Medina in
Current site
Google Scholar
PubMed
Close
 MD
,
Kishwer S. Nehal Memorial Sloan Kettering Cancer Center

Search for other papers by Kishwer S. Nehal in
Current site
Google Scholar
PubMed
Close
 MD
,
Paul Nghiem Fred Hutchinson Cancer Center

Search for other papers by Paul Nghiem in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Kelly Olino Yale Cancer Center/Smilow Cancer Hospital

Search for other papers by Kelly Olino in
Current site
Google Scholar
PubMed
Close
 MD
,
Soo Park UC San Diego Moores Cancer Center

Search for other papers by Soo Park in
Current site
Google Scholar
PubMed
Close
 MD
,
Tejesh Patel University of Tennessee Health Science Center

Search for other papers by Tejesh Patel in
Current site
Google Scholar
PubMed
Close
 MD
,
Igor Puzanov Roswell Park Comprehensive Cancer Center

Search for other papers by Igor Puzanov in
Current site
Google Scholar
PubMed
Close
 MD, MSCI
,
Jason Rich Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Search for other papers by Jason Rich in
Current site
Google Scholar
PubMed
Close
 MD
,
Aleksandar Sekulic Mayo Clinic Comprehensive Cancer Center

Search for other papers by Aleksandar Sekulic in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Ashok R. Shaha Memorial Sloan Kettering Cancer Center

Search for other papers by Ashok R. Shaha in
Current site
Google Scholar
PubMed
Close
 MD
,
Divya Srivastava UT Southwestern Simmons Comprehensive Cancer Center

Search for other papers by Divya Srivastava in
Current site
Google Scholar
PubMed
Close
 MD
,
Valencia Thomas The University of Texas MD Anderson Cancer Center

Search for other papers by Valencia Thomas in
Current site
Google Scholar
PubMed
Close
 MD
,
Courtney Tomblinson Vanderbilt-Ingram Cancer Center

Search for other papers by Courtney Tomblinson in
Current site
Google Scholar
PubMed
Close
 MD
,
Puja Venkat UCLA Jonsson Comprehensive Cancer Center

Search for other papers by Puja Venkat in
Current site
Google Scholar
PubMed
Close
 MD
,
Yaohui Gloria Xu University of Wisconsin Carbone Cancer Center

Search for other papers by Yaohui Gloria Xu in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Siegrid Yu UCSF Helen Diller Family Comprehensive Cancer Center

Search for other papers by Siegrid Yu in
Current site
Google Scholar
PubMed
Close
 MD
,
Mehran Yusuf O’Neal Comprehensive Cancer Center at UAB

Search for other papers by Mehran Yusuf in
Current site
Google Scholar
PubMed
Close
 MD
,
Beth McCullough National Comprehensive Cancer Network

Search for other papers by Beth McCullough in
Current site
Google Scholar
PubMed
Close
 RN, CMSRN
, and
Sara Espinosa National Comprehensive Cancer Network

Search for other papers by Sara Espinosa in
Current site
Google Scholar
PubMed
Close
 PhD
Restricted access

Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline an updated risk stratification and treatment options available for BCC.

Individual Disclosures for the NCCN Basal Cell Skin Cancer Panel
Individual Disclosures for the NCCN Basal Cell Skin Cancer Panel

  • Collapse
  • Expand
  • 1.

    Asgari MM, Moffet HH, Ray GT, et al. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998–2012. JAMA Dermatol 2015;151:976981.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:730.

  • 3.

    Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015;151:10811086.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Abbas M, Kalia S. Trends in non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma) in Canada: a descriptive analysis of available data. J Cutan Med Surg 2016;20:166175.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Rudolph C, Schnoor M, Eisemann N, et al. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges 2015;13:788797.

  • 6.

    Muzic JG, Schmitt AR, Wright AC, et al. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc 2017;92:890898.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681690.

  • 8.

    von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984;10:10431060.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Nguyen-Nielsen M, Wang L, Pedersen L, et al. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997–2010. Eur J Dermatol 2015;25:463468.

  • 10.

    Wadhera A, Fazio M, Bricca G, et al. Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data? Dermatol Online J 2006;12:7.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Kricker A, Armstrong BK, English DR, et al. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 1995;60:489494.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Kricker A, Armstrong BK, English DR, et al. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995;60:482488.

  • 13.

    Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case- control study. Br J Cancer 2006;94:743751.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995;131:157163.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Ramsay HM, Fryer AA, Hawley CM, et al. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003;49:397406.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Kaskel P, Lange U, Sander S, et al. Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany. J Eur Acad Dermatol Venereol 2015;29:134142.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Khalesi M, Whiteman DC, Tran B, et al. A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin. Cancer Epidemiol 2013;37:534543.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Walther U, Kron M, Sander S, et al. Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004;151:170178.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Box NF, Duffy DL, Irving RE, et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001;116:224229.

  • 20.

    Lock-Andersen J, Drzewiecki KT, Wulf HC. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Acta Derm Venereol 1999;79:7480.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Chinem VP, Miot HA. Prevalence of actinic skin lesions in patients with basal cell carcinoma of the head: a case-control study. Rev Assoc Med Bras (1992) 2012;58:188196.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Wu S, Han J, Li WQ, et al. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol 2013;178:890897.

  • 23.

    Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005;23:37333741.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Karagas MR, Nelson HH, Zens MS, et al. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 2007;18:776784.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Watt TC, Inskip PD, Stratton K, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2012;104:12401250.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Schwartz JL, Kopecky KJ, Mathes RW, et al. Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Radiat Res 2009;171:155163.

  • 27.

    Karagas MR, McDonald JA, Greenberg ER, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J Natl Cancer Inst 1996;88:18481853.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    National Institutes of Health. PubMed overview. Accessed September 1, 2023. Available at: https://pubmed.ncbi.nlm.nih.gov/about/

  • 29.

    Freedman-Cass DA, Fischer T, Alpert AB, et al. The value and process of inclusion: using sensitive, respectful, and inclusive language and images in NCCN content. J Natl Compr Canc Netw 2023;21:434441.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Lesiak A, Sobolewska-Sztychny D, Majak P, et al. Relation between sonic hedgehog pathway gene polymorphisms and basal cell carcinoma development in the Polish population. Arch Dermatol Res 2016;308:3947.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Reifenberger J, Wolter M, Weber RG, et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998;58:17981803.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Xie J, Murone M, Luoh SM, et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998;391:9092.

  • 33.

    Gailani MR, Bale SJ, Leffell DJ, et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992;69:111117.

  • 34.

    Soufir N, Gerard B, Portela M, et al. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. Br J Cancer 2006;95:548553.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Ling G, Ahmadian A, Persson A, et al. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 2001;20:77707778.

  • 36.

    Heitzer E, Lassacher A, Quehenberger F, et al. UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype. J Invest Dermatol 2007;127:28722881.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Danaee H, Karagas MR, Kelsey KT, et al. Allelic loss at Drosophila patched gene is highly prevalent in basal and squamous cell carcinomas of the skin. J Invest Dermatol 2006;126:11521158.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Reifenberger J, Wolter M, Knobbe CB, et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005;152:4351.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Kim MY, Park HJ, Baek SC, et al. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 2002;29:19.

  • 40.

    Gailani MR, Ståhle-Bäckdahl M, Leffell DJ, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996;14:7881.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41.

    Zhang H, Ping XL, Lee PK, et al. Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol 2001;158:381385.

  • 42.

    Ziegler A, Leffell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993;90:42164220.

  • 43.

    Oluwasanmi JO, Williams AO, Alli AF. Superficial cancer in Nigeria. Br J Cancer 1969;23:714728.

  • 44.

    Yakubu A, Mabogunje OA. Skin cancer in Zaria, Nigeria. Trop Doct 1995;25(Suppl 1):6367.

  • 45.

    Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241250.

  • 46.

    Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 2011;48:168176.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Kraemer KH, Lee MM, Andrews AD, et al. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994;130:10181021.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984;5:511514.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Couvé-Privat S, Le Bret M, Traiffort E, et al. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients. Cancer Res 2004;64:35593565.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Couvé-Privat S, Bouadjar B, Avril MF, et al. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res 2002;62:71867189.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Miller KL, Karagas MR, Kraft P, et al. XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis 2006;27:16701675.

  • 52.

    Clements S, Khachemoune A. Upstaging of basal cell and squamous cell carcinomas during definitive surgery: a review of predictive preoperative clinical and histologic features. Arch Dermatol Res 2021;313:319325.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Singh B, Dorelles A, Konnikov N, et al. Detection of high-risk histologic features and tumor upstaging of nonmelanoma skin cancers on debulk analysis: a quantitative systematic review. Dermatol Surg 2017;43:10031011.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54.

    Chen J, Ruczinski I, Jorgensen TJ, et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008;100:12151222.

  • 55.

    Morgan FC, Ruiz ES, Karia PS, et al. Brigham and Women’s Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death. J Am Acad Dermatol 2021;85:582587.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56.

    Gandhi MR, Panizza B, Kennedy D. Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing “targeted” MRI with the histologic findings following surgery. Head Neck 2011;33:469475.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57.

    Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001;49:10611069.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58.

    Boeta-Angeles, Bennett RG. Features associated with recurrence (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Blackwell Science; 1998:pp. 646656.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59.

    Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992;18:471476.

  • 60.

    Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation. J Dermatol Surg Oncol 1991;17:720726.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61.

    Dubin N, Kopf AW. Multivariate risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol 1983;119:373377.

  • 62.

    Bøgelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol 2007;87:330334.

  • 63.

    Rigel DS, Robins P, Friedman RJ. Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score. J Dermatol Surg Oncol 1981;7:807810.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 64.

    Spiller WF, Spiller RF. Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 1984;11:808814.

  • 65.

    van Iersel CA, van de Velden HV, Kusters CD, et al. Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol 2005;153:10781080.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66.

    Petrovich Z, Kuisk H, Langholz B, et al. Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose. Am J Surg 1987;154:447450.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 1: overview. J Dermatol Surg Oncol 1991;17:713718.

  • 68.

    Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatol Surg 2012;38:15821603.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69.

    Dixon AY, Lee SH, McGregor DH. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol 1993;20:137142.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 70.

    Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982;49:533537.

  • 71.

    de Rosa G, Vetrani A, Zeppa P, et al. Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin. Cancer 1990;65:544549.

  • 72.

    Codazzi D, Van Der Velden J, Carminati M, et al. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management. J Plast Surg Hand Surg 2014;48:3843.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 73.

    Krynitz B, Olsson H, Lundh Rozell B, et al. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study. Br J Dermatol 2016;174:95103.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74.

    Mackintosh LJ, Geddes CC, Herd RM. Skin tumours in the West of Scotland renal transplant population. Br J Dermatol 2013;168:10471053.

  • 75.

    Bernat García J, Morales Suárez-Varela M, Vilata JJ, et al. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol 2013;93:422427.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76.

    Karczewski M, Stronka M, Karczewski J, et al. Skin cancer following kidney transplantation: a single-center experience. Transplant Proc 2011;43:37603761.

  • 77.

    Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004;77:574579.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 78.

    DePry JL, Vyas R, Lazarus HM, et al. Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol 2015;151:775782.

  • 79.

    Stern RS, Liebman EJ, Väkevä L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 1998;90:12781284.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 80.

    Archier E, Devaux S, Castela E, et al. Carcinogenic risks of psoralen ultraviolet-A therapy and narrowband ultraviolet-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012;26(Suppl 3):2231.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 81.

    Park GH, Chang SE, Won CH, et al. Incidence of primary skin cancer after organ transplantation: an 18-year single-center experience in Korea. J Am Acad Dermatol 2014;70:465472.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82.

    Jensen AO, Svaerke C, Farkas D, et al. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010;90:474479.

  • 83.

    Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49:506509.

  • 84.

    Harwood CA, Mesher D, McGregor JM, et al. A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant 2013;13:119129.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85.

    Brewer JD, Colegio OR, Phillips PK, et al. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009;145:13911396.

  • 86.

    Rashtak S, Dierkhising RA, Kremers WK, et al. Incidence and risk factors for skin cancer following lung transplantation. J Am Acad Dermatol 2015;72:9298.

  • 87.

    Fortina AB, Piaserico S, Caforio AL, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004;140:10791085.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 88.

    Kanitakis J, Alhaj-Ibrahim L, Euvrard S, et al. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003;139:11331137.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89.

    Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006;54:290300.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 90.

    Lott DG, Manz R, Koch C, et al. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients. Transplantation 2010;90:683687.

  • 91.

    Martin H, Strong E, Spiro RH. Radiation-induced skin cancer of the head and neck. Cancer 1970;25:6171.

  • 92.

    Lichter MD, Karagas MR, Mott LA, et al. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2000;136:10071011.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 93.

    Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 1989;11:222232.

  • 94.

    Smeets NW, Kuijpers DI, Nelemans P, et al. Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face—results of a retrospective study and review of the literature. Br J Dermatol 2004;151:141147.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 95.

    Cigna E, Tarallo M, Maruccia M, et al. Basal cell carcinoma: 10 years of experience. J Skin Cancer 2011;2011:476362.

  • 96.

    Szewczyk MP, Pazdrowski J, Dańczak-Pazdrowska A, et al. Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma. Postepy Dermatol Alergol 2014;31:146151.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 97.

    Bartoš V, Pokorný D, Zacharová O, et al. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. Acta Dermatovenerol Alp Panonica Adriat 2011;20:6775.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 98.

    Sartore L, Lancerotto L, Salmaso M, et al. Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep 2011;26:14231429.

  • 99.

    Sloane JP. The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol 1977;96:127132.

  • 100.

    Costantino D, Lowe L, Brown DL. Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg 2006;59:424428.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 101.

    Martin RC 2nd, Edwards MJ, Cawte TG, et al. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer 2000;88:13651369.

  • 102.

    Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol 2009;60:137143.

  • 103.

    Wermker K, Roknic N, Goessling K, et al. Basosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression. Neoplasia 2015;17:301305.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 104.

    Hassanein AM, Proper SA, Depcik-Smith ND, et al. Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery. Dermatol Surg 2005;31:11011106.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 105.

    Lin C, Tripcony L, Keller J, et al. Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features. Int J Radiat Oncol Biol Phys 2012;82:334340.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 106.

    Garcia-Serra A, Hinerman RW, Mendenhall WM, et al. Carcinoma of the skin with perineural invasion. Head Neck 2003;25:10271033.

  • 107.

    Lin C, Tripcony L, Keller J, et al. Cutaneous carcinoma of the head and neck with clinical features of perineural infiltration treated with radiotherapy. Clin Oncol (R Coll Radiol) 2013;25:362367.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 108.

    Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005;53:458463.

  • 109.

    Jackson JE, Dickie GJ, Wiltshire KL, et al. Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach. Head Neck 2009;31:604610.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 110.

    Ratner D, Lowe L, Johnson TM, et al. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 2000;88:16051613.

  • 111.

    Brown CI, Perry AE. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 2000;22:123125.

  • 112.

    Galloway TJ, Morris CG, Mancuso AA, et al. Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion. Cancer 2005;103:12541257.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 113.

    Balamucki CJ, DeJesus R, Galloway TJ, et al. Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol 2015;38:248251.

  • 114.

    Cernea CR, Ferraz AR, de Castro IV, et al. Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked. ORL J Otorhinolaryngol Relat Spec 2009;71:2126.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 115.

    Leffell DJ, Headington JT, Wong DS, et al. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 1991;127:16631667.

  • 116.

    McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol 1997;133:593596.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 117.

    Bastiaens MT, Hoefnagel JJ, Bruijn JA, et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 1998;110:880884.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 118.

    Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:4147.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 119.

    Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol 2006;155:401407.

  • 120.

    Dinehart SM, Dodge R, Stanley WE, et al. Basal cell carcinoma treated with Mohs surgery. A comparison of 54 younger patients with 1050 older patients. J Dermatol Surg Oncol 1992;18:560566.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 121.

    Milroy CJ, Horlock N, Wilson GD, et al. Aggressive basal cell carcinoma in young patients: fact or fiction? Br J Plast Surg 2000;53:393396.

  • 122.

    Roudier-Pujol C, Auperin A, Nguyen T, et al. Basal cell carcinoma in young adults: not more aggressive than in older patients. Dermatology 1999;199:119123.

  • 123.

    Lear JT, Smith AG, Bowers B, et al. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction. J Invest Dermatol 1997;108:519522.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 124.

    Ramachandran S, Fryer AA, Lovatt T, et al. The rate of increase in the numbers of primary sporadic basal cell carcinomas during follow up is associated with age at first presentation. Carcinogenesis 2002;23:20512054.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 125.

    Cheretis C, Angelidou E, Dietrich F, et al. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma. Med Sci Monit 2008;14:MT13MT19.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 126.

    Karagas MR, Stukel TA, Greenberg ER, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 1992;267:33053310.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 127.

    Lovatt TJ, Lear JT, Bastrilles J, et al. Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol 2005;52:468473.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 128.

    Richmond-Sinclair NM, Pandeya N, Williams GM, et al. Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study. Int J Cancer 2010;127:26222629.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 129.

    Flohil SC, Koljenović S, de Haas ER, et al. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 2011;165:874881.

  • 130.

    Verkouteren JAC, Smedinga H, Steyerberg EW, et al. Predicting the Risk of a Second Basal Cell Carcinoma. J Invest Dermatol 2015;135:26492656.

  • 131.

    Milán T, Pukkala E, Verkasalo PK, et al. Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 2000;87:283288.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 132.

    McCusker M, Basset-Seguin N, Dummer R, et al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer 2014;50:774783.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 133.

    Kiiski V, de Vries E, Flohil SC, et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010;146:848855.

  • 134.

    Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315328.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 135.

    Barlow JO, Zalla MJ, Kyle A, et al. Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 2006;54:10391045.

  • 136.

    Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:11771183.

  • 137.

    Chren MM, Torres JS, Stuart SE, et al. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol 2011;147:540546.

  • 138.

    Julian C, Bowers PW, Pritchard C. A comparative study of the effects of disposable and Volkmann spoon curettes in the treatment of basal cell carcinoma. Br J Dermatol 2009;161:14071409.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 139.

    Blixt E, Nelsen D, Stratman E. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone. Dermatol Surg 2013;39:719725.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 140.

    Rodriguez-Vigil T, Vázquez-López F, Perez-Oliva N. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. J Am Acad Dermatol 2007;56:9195.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 141.

    Kopf AW, Bart RS, Schrager D, et al. Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977;113:439443.

  • 142.

    Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424431.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 143.

    van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer 2014;50:30113020.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 144.

    Emmett AJ, Broadbent GD. Shave excision of superficial solar skin lesions. Plast Reconstr Surg 1987;80:4754.

  • 145.

    Dando EE, Abban C, Shehu Wingrove A, et al. Deep shave removal of suspected basal cell carcinoma: a prospective study. Dermatol Surg 2023;49:130134.

  • 146.

    Abramson AK, Krasny MJ, Goldman GD. Tangential shave removal of basal cell carcinoma. Dermatol Surg 2013;39:387392.

  • 147.

    Wu X, Elkin EB, Jason Chen CS, et al. Traditional versus streamlined management of basal cell carcinoma (BCC): a cost analysis. J Am Acad Dermatol 2015;73:791798.

  • 148.

    Kuijpers DI, Thissen MR, Berretty PJ, et al. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg 2007;33:579587.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 149.

    Rhodes LE, de Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007;143:11311136.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 150.

    Wetzig T, Woitek M, Eichhorn K, et al. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up. Dermatology 2010;220:363369.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 151.

    Schell AE, Russell MA, Park SS. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery. JAMA Facial Plast Surg 2013;15:337343.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 152.

    Quazi SJ, Aslam N, Saleem H, et al. Surgical margin of excision in basal cell carcinoma: a systematic review of literature. Cureus 2020;12:e9211.

  • 153.

    Bisson MA, Dunkin CS, Suvarna SK, et al. Do plastic surgeons resect basal cell carcinomas too widely? A prospective study comparing surgical and histological margins. Br J Plast Surg 2002;55:293297.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 154.

    Gulleth Y, Goldberg N, Silverman RP, et al. What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg 2010;126:12221231.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 155.

    Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg 2003;112:5763.

  • 156.

    Fraga SD, Besaw RJ, Murad F, et al. Complete margin assessment versus sectional assessment in surgically excised high-risk keratinocyte carcinomas: a systematic review and meta-analysis. Dermatol Surg 2022;48:704710.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 157.

    Su SY, Giorlando F, Ek EW, et al. Incomplete excision of basal cell carcinoma: a prospective trial. Plast Reconstr Surg 2007;120:12401248.

  • 158.

    Farhi D, Dupin N, Palangié A, et al. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Dermatol Surg 2007;33:12071214.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 159.

    Kappelin J, Nielsen K, Nilsson F, et al. Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision. J Eur Acad Dermatol Venereol 2020;34:25182525.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 160.

    Dieu T, Macleod AM. Incomplete excision of basal cell carcinomas: a retrospective audit. ANZ J Surg 2002;72:219221.

  • 161.

    Ramdas K, van Lee C, Beck S, et al. Differences in rate of complete excision of basal cell carcinoma by dermatologists, plastic surgeons and general practitioners: a large cross-sectional study. Dermatology 2018;234:8691.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 162.

    Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990;23:11181126.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 163.

    Sherry KR, Reid LA, Wilmshurst AD. A five year review of basal cell carcinoma excisions. J Plast Reconstr Aesthet Surg 2010;63:14851489.

  • 164.

    Griffiths RW, Suvarna SK, Stone J. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper? J Plast Reconstr Aesthet Surg 2007;60:4147.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 165.

    Masud D, Moustaki M, Staruch R, et al. Basal cell carcinomata: risk factors for incomplete excision and results of re-excision. J Plast Reconstr Aesthet Surg 2016;69:652656.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 166.

    Malik V, Goh KS, Leong S, et al. Risk and outcome analysis of 1832 consecutively excised basal cell carcinomas in a tertiary referral plastic surgery unit. J Plast Reconstr Aesthet Surg 2010;63:20572063.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 167.

    Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340344.

  • 168.

    Weesie F, Naus NC, Vasilic D, et al. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study. Br J Dermatol 2019;180:11761182.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 169.

    Drucker AM, Adam GP, Rofeberg V, et al. Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta- analysis. Ann Intern Med 2018;169:456466.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 170.

    Wennberg AM, Larkö O, Stenquist B. Five-year results of Mohs’ micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 1999;79:370372.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 171.

    Veronese F, Farinelli P, Zavattaro E, et al. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol 2012;26:838843.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 172.

    Litwin AS, Rytina E, Ha T, et al. Management of periocular basal cell carcinoma by Mohs micrographic surgery. J Dermatolog Treat 2013;24:232234.

  • 173.

    Sin CW, Barua A, Cook A. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study. Int J Dermatol 2016;55:10441047.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 174.

    Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005;53:452457.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 175.

    Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004;111:631636.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 176.

    Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol 2008;9:11491156.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 177.

    Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004;364:17661772.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 178.

    Muller FM, Dawe RS, Moseley H, et al. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg 2009;35:13491354.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 179.

    Gniadecki R, Glud M, Mortensen K, et al. Favourable results of Mohs micrographic surgery for basal cell carcinoma. Dan Med J 2015;62:A5171.

  • 180.

    Flohil SC, van Dorst AM, Nijsten T, et al. Mohs micrographic surgery for basal cell carcinomas: appropriateness of ‘Rotterdam’ criteria and predictive factors for three or more stages. J Eur Acad Dermatol Venereol 2013;27:12281235.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 181.

    Takata Pontes L, Fantelli Stelini R, Cintra ML, et al. The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital. Clinics (Sao Paulo) 2015;70:721725.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 182.

    Morris DS, Elzaridi E, Clarke L, et al. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure. Br J Ophthalmol 2009;93:474476.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 183.

    Mendenhall WM, Amdur RJ, Hinerman RW, et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 2009;119:19941999.

  • 184.

    Mendenhall WM, Ferlito A, Takes RP, et al. Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol 2012;48:918922.

  • 185.

    Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer 2007;109:10531059.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 186.

    Wilder RB, Kittelson JM, Shimm DS. Basal cell carcinoma treated with radiation therapy. Cancer 1991;68:21342137.

  • 187.

    Wilder RB, Shimm DS, Kittelson JM, et al. Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol 1991;127:16681672.

  • 188.

    Childers BJ, Goldwyn RM, Ramos D, et al. Long-term results of irradiation for basal cell carcinoma of the skin of the nose. Plast Reconstr Surg 1994;93:11691173.

  • 189.

    Hernández-Machin B, Borrego L, Gil-García M, et al. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007;46:453459.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 190.

    Silverman MK, Kopf AW, Gladstein AH, et al. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992;18:549554.

  • 191.

    Zagrodnik B, Kempf W, Seifert B, et al. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003;98:27082714.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 192.

    Cognetta AB, Howard BM, Heaton HP, et al. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol 2012;67:12351241.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 193.

    Avril MF, Auperin A, Margulis A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76:100106.

  • 194.

    Petit JY, Avril MF, Margulis A, et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000;105:25442551.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 195.

    Hall VL, Leppard BJ, McGill J, et al. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986;37:3334.

  • 196.

    Garcia-Martin E, Gil-Arribas LM, Idoipe M, et al. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol 2011;95:13931396.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 197.

    Zaorsky NG, Lee CT, Zhang E, et al. Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis. Radiother Oncol 2017;125:1320.

  • 198.

    Ashby MA, Pacella JA, de Groot R, et al. Use of a radon mould technique for skin cancer: results from the Peter MacCallum Cancer Institute (1975–1984). Br J Radiol 1989;62:608612.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 199.

    Cipriani C, Desantis M, Dahlhoff G, et al. Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study. J Dermatolog Treat 2022;33:969975.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 200.

    Sedda AF, Rossi G, Cipriani C, et al. Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma. Clin Exp Dermatol 2008;33:745749.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 201.

    Guibert M, David I, Vergez S, et al. Brachytherapy in lip carcinoma: long-term results. Int J Radiat Oncol Biol Phys 2011;81:e839e843.

  • 202.

    Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C, et al. Two years results of electronic brachytherapy for basal cell carcinoma. J Contemp Brachytherapy 2017;9:251255.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 203.

    Bhatnagar A, Loper A. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer. Radiat Oncol 2010;5:87.

  • 204.

    Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56:125143.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 205.

    Jansen MHE, Mosterd K, Arits AH, et al. Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma. J Invest Dermatol 2018;138:527533.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 206.

    Drew BA, Karia PS, Mora AN, et al. Treatment patterns, outcomes, and patient satisfaction of primary epidermally limited nonmelanoma skin cancer. Dermatol Surg 2017;43:14231430.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 207.

    Afsar FS, Erkan CD, Karaca S. Clinical practice trends in cryosurgery: a retrospective study of cutaneous lesions. Postepy Dermatol Alergol 2015;32:8893.

  • 208.

    Peris K, Campione E, Micantonio T, et al. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg 2005;31:318323.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 209.

    Eigentler TK, Kamin A, Weide BM, et al. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol 2007;57:616621.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 210.

    Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004;50:722733.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 211.

    Schulze HJ, Cribier B, Requena L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005;152:939947.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 212.

    Quirk C, Gebauer K, De’Ambrosis B, et al. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis 2010;85:318324.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 213.

    Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001;44:807813.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 214.

    Gollnick H, Barona CG, Frank RG, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 2008;18:677682.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 215.

    McKay KM, Sambrano BL, Fox PS, et al. Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC. Br J Dermatol 2013;169:549554.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 216.

    Bath-Hextall F, Ozolins M, Armstrong SJ, et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 2014;15:96